Abstract
Purpose
The pediatric population is represented by a diverse group of patients and, as a consequence, additional factors and parameters determining their dosage and taste must be taken into account. The aim of this work is to prepare and analyze an innovative chewable solid drug formulation that would appeal to pediatric patients. In particular, the present study presents a new taste masking processing wherein the drug’s disagreeable taste and the associated unpleasant throat burning sensation are covered with honey and chocolate.
Methods
Ibuprofen was used as the active pharmaceutical ingredient dispersed in formula after being suitably pretreated. Honey and agar are the two main excipients of the formulation while the new pharmaceutical preparation is further coated with milk chocolate to mask its bitter taste. Vitamins A and E were also added in a separate formula as an alternative choice which, apart from the curative action of ibuprofen, display additional benefits. During the development of the analytical methods, liquid/solid and solid phase extraction was performed. Moreover, for the chromatographic determination, a RP-C18 column and two different mobile phases containing acetonitrile and phosphate buffer were used.
Results
The methods were validated on the basis of international guidelines. The recoveries of the active ingredients were 97–102% while the RSD values were 0.06–0.53%. The new preparation was found to be stable for at least 1 year.
Conclusions
Considering children’s difficulty in swallowing medicines with a bitter taste, palatable ibuprofen formulations were made. Their preparative and analytic methods were validated according to ICH guidelines.
Similar content being viewed by others
References
Mennella JA, Pepino MY, Reed DR. Genetic and environmental determinants of bitter perception and sweet preferences. Pediatrics. 2005;115(2):216–22.
RegulationECNo.1901/2006, http://eurlex.europa.eu/LexUriServ/LexUriServ.do/ uri=OJ:L:2006:378:0001:0019, 2013.
Mennella JA, Beauchamp GK. Optimizing oral medications for children. Clin.Ther. 2008;30:2120–32.
http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002, 2013.
Abraham J, Flowerlet M. Taste masking of peadiatric formulation: a review on technologies, recent trends and regulatory aspects. Int J Pharm Pharm Sci. 2014;6:1.
Walsh J, Cram A, Woertz K, Breitkreutz J, Winzenburg G, Turner R, et al. On behalf of the European Formulation Initiative (EuPFI): playing hide and seek with poorly tasting paediatric medicines: do not forget the excipients. Adv Drug Deliv Rev. 2014;73:14–33.
Reiland Thomas L, Lipari John M. Encyclopedia of pharmaceutical technology. 3rd ed: Flavours and flavor modifiers. p. 1763–72.
Sharma S, Lewis S. Taste masking technologies: a review. Int J Pharm Pharm Sci. 2010;2(2):6–13.
Lieberman HA, Lachman L. Chewable tablets. In: Pharmaceutical dosage forms, vol. 1. New York: Marcel Dekker Inc; 1981. p. 387–91.
Roy G. Modifying bitterness, Technomic Publishing Co, London England; 1997. p. 179-211.
tripithi A, parmar D, patel U, patel G. Taste masking: novel approach for bitter and obnoxious drugs. JPSBR. 2011;1(3):136–42.
Deasy. Ion exchange resin in microencapsulation. Newyork: Marcel Dekker Inc; 1980. p. 150.
Wehling F., Schuehle S. Effervescent dosage forms with microparticles. US Patent 5,178,878, 1993.
Sohi H, Sultana Y, Khar RK. Taste masking technologies in oral pharmaceuticals: recent developments and approaches. Drug Dev Ind Pharm. 2004;30:429–48.
Depalmo GA. Composition based on ibuprofen, for oral usage. Eur Pat Appl. 1993;EP0560207.
Lankford BL, Becker CH. The use of some imitation flavors for masking distasteful drugs. I. Ammonium chloride. J Am Pharm Assoc. 1951;XL(2):77–82.
Ueki T., Kameda S., Uno D., Kaneko K. Dentifrices composition. JP 05,155,744, June 22, 1993.
Fuisz R. C. Taste masking of pharmaceutical floss with phenol. US Patent 5,028,632, July 2, 1991.
Palace V, Khaper N, Qin Q, Singal P. Antioxidant potentials of vitamin A and carotenoids and their relevance to heart disease. Free Radic Biol Med. 1999;26, Issues(5–6):746–61.
Herrera E, Barbas C. Vitamin E: action, metabolism and perspectives. J Physiol Biochem. 2011;57(1):43–56.
Eraga SO, Arhewoh MI, Chibuogwu RN, Iwuagwu MA. A comparative UV−HPLC analysis of ten brands of ibuprofen tablets. Asian Pac J Trop Biomed. 2015;5(10):880–4.
Huidobro AL, Rupérez FJ, Barbas C. Tandem column for the simultaneous determination of arginine, ibuprofen and related impurities by liquid chromatography. J Chromatogr A. 2006;1119(1–2, 30):238–45.
Moreno P, Salvadó V. Determination of eight water- and fat-soluble vitamins in multi-vitamin pharmaceutical formulations by high-performance liquid chromatography. J Chromatogr A. 2000;870(1–2):207–15.
Woollarda DC, Bensch A, Indyk H, Mahon AM. Determination of vitamin A and vitamin E esters in infant formulae and fortified milk powders by HPLC: use of internal standardization. Food Chem. 2016;197:457–65.
Plozza T, Trenerry VC, Caridi D. The simultaneous determination of vitamins A, E and β-carotene in bovine milk by high performance liquid chromatography–ion trap mass spectrometry (HPLC–MSn). Food Chem. 2012;134(1):559–63.
Gleize B, Stei M, André M, Reboul E. Simple and fast HPLC method for simultaneous determination of retinol, tocopherols, coenzyme Q10 and carotenoids in complex samples. Food Chem. 2012;134(4):2560–4.
Mata-Granados JM, de Castro ML, Quesada JM. Fully automated method for the determination of 24,25(OH)2 and 25(OH) D3 hydroxyvitamins, and vitamins A and E in human serum by HPLC. J Pharm Biomed Anal. 2004;35(3):575–82.
Popescu M. C., Mertz E. T. Taste moderating pharmaceutical. US Patent 5,009,819, April 23, 1991.
Kurtz R. J., Fuller W. D. Ingestibles containing substantially tasteless sweetness inhibitors as bitter taste reducers or substantially tasteless bitter inhibitors as sweet taste reducers. US Patent 5,232,735, 1993.
Nakov N, Petkovska R, Ugrinova L, Kavrakovski Z, Dimitrovska A, Svinarov D. Critical development by design of a rugged HPLC-MS/MS method for direct determination of ibuprofen enantiomers in human plasma. J Chromatogr B. 2015;992(15):67–75.
Reddy YR, Kumar KK, Mukkanti K, Reddy MRP. RP-UPLC method development and validation for the simultaneous estimation of ibuprofen and famotidine in pharmaceutical dosage form. Pharm Methods. 2012;3(2):57–61.
Naidong W, Lee JW. Development and validation of a liquid chromatographic method for the quantitation of ibuprofen enantiomers in human plasma. J Pharm Biomed Anal. 1994;12(4):551–6.
Bonato PS, Perpetua M, Lama F, de Carvalho R. Enantioselective determination of ibuprofen in plasma by high-performance liquid chromatography–electrospray mass spectrometry. J Chromatogr B. 2003;796(2):413–20.
https://en.wikipedia.org/wiki/Ibuprofen
Adams SS. The propionic acids: a personal perspective. J Clin Pharmacol. 1992;32(4):317–23.
Rainsford KD. Ibupropfen, a critical bibliographic review: Tailor and Francis; 2005.
Walter K, Weiss G, Laichern A, Stanislaus F. Pharmacokinetics of ibuprofen following a single administration of a suspension containing enteric-coated microcapsules, pubmed.gov, 1995.
Urvi G, Harsh C. Taste masking in pharmaceutical industry. Am Pharm Rev. 2014.
Breslin PA, Gingrich TN, Green BG. Ibuprofen as a chemesthetic stimulus: evidence of a novel mechanism of throat irritation. Chem Senses. 2001;26:55–65.
Hu Y, Pan J, Liao W, Li J, Gruget P, Kitts D, et al. Determination of antioxidant capacity and phenolic content of chocolate by attenuated total reflectance-Fourier transformed-infrared spectroscopy. Food Chem. 2016;202:254–61.
ICH. Harmonized tripartite guideline: validation of analytical procedures: text and methodology Q2(R1). 4th ed: EMEA; 2006.
US Pharmacopoeia (USP 29), Ibuprofen tablets.
Author information
Authors and Affiliations
Corresponding author
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Electronic Supplementary Material
ESM 1
(DOCX 15 kb)
Supplementary Figure 1
(PNG 503 kb)
Supplementary Figure 2
(PNG 16 kb)
Supplementary Figure 3
(PNG 30 kb)
Supplementary Figure 4
(PNG 76 kb)
Supplementary Table 1
(DOCX 13 kb)
Supplementary Table 2
(DOCX 14 kb)
Rights and permissions
About this article
Cite this article
Synaridou, M.S., Morichovitou, A.K. & Markopoulou, C.K. Innovative Pediatric Formulations: Ibuprofen in Chocolate-Coated Honey Core. J Pharm Innov 15, 404–415 (2020). https://doi.org/10.1007/s12247-019-09389-1
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12247-019-09389-1